Integrating Liquid Biopsy in Pathology: A New Era in Non- Invasive Cancer Diagnostics

Authors

Liquid biopsy, cancer diagnostics, pathology, non-invasive testing, biomarker analysis, early detection, personalized medicine, cancer management

Cancer diagnosis traditionally relies on tissue biopsies, which can be invasive, painful, and

sometimes inconclusive. Liquid biopsy, a non-invasive alternative, has emerged as a

promising tool in the early detection, monitoring, and prognosis of cancer. By analyzing

biomarkers present in bodily fluids such as blood, urine, and saliva, liquid biopsies can

provide valuable genetic, epigenetic, and proteomic information about tumors. This paper

explores the integration of liquid biopsy into pathology, highlighting its potential, limitations,

and the technical advancements necessary for its widespread adoption in clinical practice.

Furthermore, the future prospects of liquid biopsy in personalized medicine and cancer

management are discussed.